Medtronic, Inc. (MDT) PT Lowered to $122 at RBC Capital

May 27, 2022 6:24 AM

RBC Capital analyst Shagun Singh lowered the price target on Medtronic, Inc. (NYSE: MDT) to $122.00 (from $135.00) while maintaining a Outperform rating.

No results found